SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-584709
Filing Date
2016-05-10
Accepted
2016-05-10 07:29:14
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q d145738d10q.htm 10-Q 389175
2 EX-31.1 d145738dex311.htm EX-31.1 5413
3 EX-31.2 d145738dex312.htm EX-31.2 5400
4 EX-32.1 d145738dex321.htm EX-32.1 3450
5 EX-32.2 d145738dex322.htm EX-32.2 3437
  Complete submission text file 0001193125-16-584709.txt   3485077

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dnai-20160331.xml EX-101.INS 560704
7 XBRL TAXONOMY EXTENSION SCHEMA dnai-20160331.xsd EX-101.SCH 49900
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dnai-20160331_cal.xml EX-101.CAL 50693
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dnai-20160331_def.xml EX-101.DEF 173819
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dnai-20160331_lab.xml EX-101.LAB 418133
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dnai-20160331_pre.xml EX-101.PRE 287849
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
ProNAi Therapeutics Inc (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 161633691
SIC: 2834 Pharmaceutical Preparations